Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Promising advance in fight against African swine fever
African swine fever virus is a devastating and economically important disease of pigs.
Researchers identify novel proteins to test as vaccine candidates 

Scientists at The Pirbright Institute have made a promising advance in the quest for an African swine fever vaccine.

Writing in the Journal of Virology, researchers describe how they have identified a number of novel immunogenic proteins to test further as vaccine candidates.

“Such an advance is extremely timely due to the continuing spread of ASFV into Eastern Europe,” explained study leader Dr Linda Dixon. “Developing an effective and safe vaccine is therefore of increasing importance to prevent further spread.”

African swine fever virus (ASFV) is a devastating and economically important disease of pigs that is usually fatal. Prevalent in Russia, Sardinia, Sub-Saharan Africa and Eastern Europe, experts have warned that the disease is likely to spread further afield.

There is no vaccine available for ASFV which limits the available options for control. However, researchers at Pirbright have been working on a solution.

Until now, ASF vaccine development work has centred on live attenuated viruses. These are common viruses that have been genetically modified to prevent a full infection, but which can still trigger an immune response.

Although this method is common and effective, scientists say there may be safety issues since the vaccine may cause clinical signs and persist in animals. To overcome this problem, Dr Linda Dixon and her team set out to investigate proteins that induce immune responses that might offer the best protection against infection.

By inserting the gene code for these proteins into Vaccinia - a safe virus that is often used to deliver protective genes to a host - they were able to screen 30 per cent of ASFV genome and ranked 47 genes on their ability to produce proteins that would generate an immune response in pigs.

Researchers say the next step is to test the proteins that had the best immune response and incorporate them into safe vaccines that could eventually be used in the field.

 

Become a member or log in to add this story to your CPD history

Voting opens for BEVA Council

News Story 1
 Eligible members of BEVA will be able to vote for their Council team until Monday, 17 August 2026. Members will have received an election email on 17 July.

There are five candidates standing for four available places on Council. They are:

  • Alexandre Triguino
  • Angela Jones
  • Beth Bryant
  • Holly Rees
  • Hugh Somerville
Full profiles for each candidate can be found on the BEVA website

Click here for more...
News Shorts
Milk recalled over presence of veterinary medicines

Graham's Family Dairy has issued a recall for its semi-skimmed milk due to the presence of veterinary medicines in the product.

In a risk statement, the Food Standards Agency said the presence of the medicines, including penicillin, make the milk unsafe to consume and 'may be a possible health risk for anyone with an allergy to antibiotics'.

Customers who bought the product are advised to return it to the store of purchase for a full refund.